CD274 and neoplasm: Therapeutic molecules, including chemotherapeutics and anti-PDL1 antibody, can be delivered to and released within tumor cells or TME by ROS-responsive prodrugs or nanoparticles [243,244,245,246,247,248], resulting in significant inhibition of tumor cell growth both in vitro and in vivo.